Agenus (AGEN) Research & Development (2010 - 2026)
Agenus' Research & Development came in at $14.76 million for Q2 2026, down 44.7% from $26.71 million a year earlier but up 24.8% from the prior quarter.
Powered by 
Analysis
Agenus (AGEN) Research & Development (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Agenus reported Research & Development of $57.69 million, down 53.1% year-over-year; for FY2025, it was $79.34 million, down 49.0% from FY2024.
- Research & Development carries a five-year compound annual growth rate of -11.1% (FY2020 to FY2025).
- Going back by year, Research & Development was $155.53 million in FY2024 (-33.7%), $234.57 million in FY2023 (+25.6%), $186.69 million in FY2022 (+4.5%) and $178.61 million in FY2021 (+25.2%).
- The five-year range for quarterly Research & Development is $7.51 million (Q4 2025) to $66.72 million (Q4 2023).
- Year-over-year, Research & Development has declined for ten consecutive quarters, with an average decline of 44.8% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q4 2021 (growth of 50.4%), and the weakest in Q4 2025 (a decline of 77.8%).
- Business Quant data shows AGEN's Research & Development at $11.82 million (Q1 2026), $7.51 million (Q4 2025) and $23.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Agenus | 401.87 Mn | 395.09 Mn | 34.52 Mn | 14.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.76 Mn |
| Mar 31, 2026 | 11.82 Mn |
| Dec 31, 2025 | 7.51 Mn |
| Sep 30, 2025 | 23.60 Mn |
| Jun 30, 2025 | 26.71 Mn |
| Mar 31, 2025 | 21.52 Mn |
| Dec 31, 2024 | 33.78 Mn |
| Sep 30, 2024 | 41.06 Mn |
| Jun 30, 2024 | 36.77 Mn |
| Mar 31, 2024 | 43.93 Mn |
| Dec 31, 2023 | 66.72 Mn |
| Sep 30, 2023 | 51.44 Mn |
| Jun 30, 2023 | 59.29 Mn |
| Mar 31, 2023 | 57.12 Mn |
| Dec 31, 2022 | 53.28 Mn |
| Sep 30, 2022 | 46.01 Mn |
| Jun 30, 2022 | 44.96 Mn |
| Mar 31, 2022 | 42.44 Mn |
| Dec 31, 2021 | 53.49 Mn |
| Sep 30, 2021 | 42.94 Mn |
API Access
Agenus Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();